- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Zydus Lifesciences Limited — Updates, 13-03-2026: Press Release
13-03-2026 | 10:02 am
13-03-2026 | 10:02 am
Zydus secures USFDA clearance for Cevimeline Hydrochloride Capsules 30mg, targeting dry mouth. This approval taps into a product with annual sales of USD 26.9 mn, strengthening their portfolio.
No comments yet. Be the first to comment!